The Canonsburg, Pa.-based drugmaker will sell a two-pack of the generic epinephrine auto-injectors for $300, a more than 50 percent discount from EpiPen’s $608 list price.
Mylan has faced intense public scrutiny this year over the high price of EpiPens, which only cost $100 per two-pack in 2008, reports Reuters. The drugmaker announced plans to release a generic EpiPen in August as a response to the pricing controversy.
In October, the drugmaker reached a $465 million settlement with the federal government over accusations it improperly classified EpiPens as a generic drug to overcharge Medicaid.
More articles on supply chain:
Amazon conducts first drone delivery to a customer
McKesson, Infor form go-to-market partnership: 3 things to know
American Red Cross needs donors amid seasonal blood shortage
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.